SpineThera
Dr. Houghton was formerly the Chief Medical Officer at Xenome, Anesiva, and Orphan Medical, and completed his Anesthesiology residency at Sydney University, Sydney, Australia. Bill provides guidance and insight to optimize SpineThera's pre-clinical and clinical study plans and defines product requirements from the clinical perspective.
This person is not in any offices
SpineThera
SpineThera designs and develops sustained-release, injectable drugs to meet the unique safety requirements for administration in and near the spine.